Drug Sales Rep Indicted For Off-Label Marketing Of $330,000 Cholesterol Drug

Mealey's (August 15, 2018, 8:18 AM EDT) -- BOSTON — A drug sales representative was indicted Aug. 7 in the U.S. District Court for the District of Massachusetts for wire fraud and identity theft in connection with the alleged off-label marketing of an expensive cholesterol drug (United States v. Mark Moffett, No. 18-cr-10249, D. Mass.)....

Attached Documents

Related Sections